(Q40522528)

21 September 2017

1 reference

title

Proteolysis and invasiveness of brain tumors: role of urokinase-type plasminogen activator receptor (English)

1 reference

21 September 2017

1 reference

1 reference

neoplastic invasiveness

1 reference

S Mohanam

1

1 reference

21 September 2017

R E Sawaya

2

1 reference

21 September 2017

M Yamamoto

3

1 reference

21 September 2017

J M Bruner

4

1 reference

21 September 2017

G L Nicholson

5

1 reference

21 September 2017

J S Rao

6

1 reference

21 September 2017

1 January 1994

1 reference

Journal of Neuro-Oncology

21 September 2017

1 reference

21 September 2017

22

1 reference

21 September 2017

2

1 reference

21 September 2017

153-160

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01052890

21 September 2017

0 references

cites work

Differential inhibition of soluble and cell surface receptor-bound single-chain urokinase by plasminogen activator inhibitor type 2. A potential regulatory mechanism.

1 reference

12 December 2020

Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins

1 reference

12 December 2020

Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer

1 reference

12 December 2020

Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor

1 reference

12 December 2020

Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation

1 reference

12 December 2020

The urokinase receptor: involvement in cell surface proteolysis and cancer invasion

1 reference

12 December 2020

Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants

1 reference

12 December 2020

Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts

1 reference

12 December 2020

Receptor-mediated endocytosis of plasminogen activators and activator/inhibitor complexes

1 reference

12 December 2020

Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate

1 reference

12 December 2020

Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells

1 reference

12 December 2020

Structure and function of the urokinase receptor

1 reference

12 December 2020

Inhibition of urokinase-type plasminogen activator by antibodies: the effect on dissemination of a human tumor in the nude mouse

1 reference

12 December 2020

Complementation between urokinase-producing and receptor-producing cells in extracellular matrix degradation

1 reference

12 December 2020

Cell-induced potentiation of the plasminogen activation system is abolished by a monoclonal antibody that recognizes the NH2-terminal domain of the urokinase receptor

1 reference

12 December 2020

The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator

1 reference

12 December 2020

Plasminogen activator-dependent pericellular proteolysis

1 reference

12 December 2020

Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA)

1 reference

12 December 2020

Plasminogen activator inhibitors: hormonally regulated serpins

1 reference

12 December 2020

Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor

1 reference

12 December 2020

The role of proteolytic enzymes in cancer invasion and metastasis

1 reference

12 December 2020

Binding of the urokinase-type plasminogen activator to its cell surface receptor is inhibited by low doses of suramin.

1 reference

12 December 2020

Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes

1 reference

12 December 2020

Invasion of brain tissue by primary glioma: evidence for the involvement of urokinase-type plasminogen activator as an activator of type IV collagenase

1 reference

12 December 2020

Plasminogen activator activity and molecular weight patterns in human brain tumors

1 reference

12 December 2020

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

1 reference

12 December 2020

Isolation and characterization of multiple isoforms of the rat urokinase receptor in osteoblasts

1 reference

12 December 2020

Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody.

1 reference

12 December 2020

In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion

1 reference

12 December 2020

Elevated levels of urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 in malignant human brain tumors.

1 reference

12 December 2020

Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor

1 reference

12 December 2020

Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis

1 reference

12 December 2020

The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes

1 reference

12 December 2020

Plasminogen activators and cancer

1 reference

12 December 2020

Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activator

1 reference

12 December 2020

Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes

1 reference

12 December 2020

Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors

1 reference

12 December 2020

Effects of urokinase receptor occupancy on plasmin generation and proteolysis of basement membrane by human tumor cells

1 reference

12 December 2020

Structure of vitronectin and its biological role in haemostasis

1 reference

12 December 2020

Plasminogen activators, tissue degradation, and cancer

1 reference

12 December 2020

Assignment of the urokinase-type plasminogen activator receptor gene (PLAUR) to chromosome 19q13.1-q13.2

1 reference

12 December 2020

An alternatively spliced variant of mRNA for the human receptor for urokinase plasminogen activator

1 reference

12 December 2020

Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract

1 reference

12 December 2020

Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol

1 reference

12 December 2020

Directed plasminogen activation at the surface of normal and malignant cells

1 reference

12 December 2020

Cathepsin B and its endogenous inhibitors: the role in tumor malignancy

1 reference

12 December 2020

Plasminogen activator inhibitor type I stabilizes vitronectin-dependent adhesions in HT-1080 cells

1 reference

12 December 2020

Endogenous receptor-bound urokinase mediates tissue invasion of the human lung carcinoma cell lines A549 and Calu-1

1 reference

12 December 2020

Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01052890

1 reference

Dimensions Publication ID

21 September 2017

0 references

1 reference